Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Familial bladder cancer]

A Terai1

  • 1Department of Urology, Faculty of Medicine, Kyoto University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Genetic factors in bladder cancer include rare dominant inheritance and polygenic patterns, like glutathione S-transferase M1 gene defects. Molecular analysis reveals distinct pathways involving chromosome 9 loss and p53 gene mutations in tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men.

Prostate cancer and prostatic diseases·2008
Same author

Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men.

Prostate cancer and prostatic diseases·2007
Same author

Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients.

Prostate cancer and prostatic diseases·2007
Same author

Risk factors for renal cysts.

BJU international·2004
Same author

A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.

Prostate cancer and prostatic diseases·2004
Same author

Non-secretor status is associated with female acute uncomplicated pyelonephritis.

BJU international·2002

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Bladder cancer etiology is complex, with limited evidence for hereditary causes in most cases.
  • Two genetic involvement patterns are proposed: autosomal dominant (rare) and multifactorial polygenic (common).
  • The glutathione S-transferase M1 gene defect exemplifies the polygenic inheritance pattern.

Purpose:

  • To explore the genetic underpinnings of bladder cancer development.
  • To identify distinct molecular pathways in bladder tumorigenesis.
  • To evaluate the prognostic potential of genetic alterations.

Summary:

  • Molecular genetic analysis reveals two pathways: chromosome 9 allelic loss in papillary and invasive tumors, and p53 gene mutations in carcinoma in situ.
  • p53 gene mutations correlate with high-grade, high-stage urothelial cancers.

Related Experiment Videos

  • Immunohistochemical detection of p53 alterations may serve as a prognostic marker.

    • Impact:

    • Understanding genetic pathways aids in identifying bladder cancer risk factors.
    • p53 protein detection offers a potential prognostic tool for urothelial cancers.
    • Findings suggest a monoclonal origin for multicentric urothelial cancers, impacting treatment strategies.